Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A26626 | 20076826 | J Gastrointestin Liver Dis | Two cases of non-alcoholic steato-hepatitis developing from simple fatty liver. | 2009 | Details |
A26628 | 20066503 | Obes Surg | Hypoadiponectinemia and its association with liver fibrosis in morbidly obese patients. | 2010 | Details |
A26629 | 20064693 | Med Hypotheses | Impact of ecology on development of NIDDM. | 2010 | Details |
A26638 | 20042103 | Lipids Health Dis | Transgenic fat-1 mouse as a model to study the pathophysiology of cardiovascular, neurological and psychiatric disorders. | 2009 | Details |
A26642 | 24149634 | J Sports Sci Med | Association of cardiorespiratory fitness with elevated hepatic enzyme and liver fat in Japanese patients with impaired glucose tolerance and type 2 diabetes mellitus. | 2010 | Details |
A26651 | 21387764 | Przegl Lek | [Non-alcoholic fatty liver disease (NAFLD) in patients with metabolic syndrome and type 2 diabetes mellitus. Pathomechanism, new diagnostic markers]. | 2010 | Details |
A26653 | 20040915 | Am J Gastroenterol | Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil". | 2009 | Details |
A26656 | 20038265 | Immunopharmacol Immunotoxicol | Metformin regulates palmitate-induced apoptosis and ER stress response in HepG2 liver cells. | 2010 | Details |
A26657 | 20036859 | Front Biosci (Elite Ed) | Biochemical characteristics and risk factors in non-alcoholic fatty liver. | 2010 | Details |
A26675 | 20002475 | Diabet Med | Abnormal liver function tests in patients with Type 1 diabetes mellitus: prevalence, clinical correlations and underlying pathologies. | 2009 | Details |
A26693 | 19945407 | Cell Metab | Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein. | 2009 | Details |
A26697 | 19938136 | Liver Transpl | Posttransplant metabolic syndrome: an epidemic waiting to happen. | 2009 | Details |
A26704 | 19929783 | Curr Med Chem | Branched-chain amino acids and pigment epithelium-derived factor: novel therapeutic agents for hepatitis c virus-associated insulin resistance. | 2009 | Details |
A26708 | 19923096 | Orv Hetil | [Role of the endocrine system in the pathogenesis of non-alcoholic fatty liver disease]. | 2009 | Details |
A26709 | 19921118 | Adv Ther | Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status. | 2009 | Details |
A26718 | 19908945 | J Immunotoxicol | Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease. | 2009 | Details |
A26719 | 19904291 | Eur J Clin Nutr | Relationship between body mass index and alanine aminotransferase concentration in non-diabetic Korean adults. | 2009 | Details |
A26729 | 19886070 | Rom J Intern Med | Nonalcoholic fatty liver disease--a risk factor for microalbuminuria in type 2 diabetic patients. | 2009 | Details |
A26768 | 19818304 | Clin Liver Dis | Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis. | 2009 | Details |
A26776 | 19809879 | Rev Endocr Metab Disord | Identification and treatment of metabolic complications in pediatric obesity. | 2009 | Details |
A26782 | 19793175 | J Gastroenterol Hepatol | Serum ornithine carbamyltransferase reflects hepatic damage in diabetic obese mice. | 2009 | Details |
A26789 | 19781663 | Biochim Biophys Acta | n-3 PUFA and lipotoxicity. | 2009 | Details |
A26791 | 19779336 | Curr Opin Lipidol | Thiazolidinediones and the liver in humans. | 2009 | Details |
A26793 | 19777393 | Curr Opin Investig Drugs | Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis. | 2009 | Details |
A26797 | 19766548 | Dig Liver Dis | Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. | 2009 | Details |
A26812 | 19733470 | J Nutr Biochem | Lipoprotein metabolism mediates the association of MTP polymorphism with beta-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis. | 2009 | Details |
A26816 | 19728847 | Clin Chem Lab Med | A case-control study on the relationship between HDL2b and non-alcoholic fatty liver disease in Chinese type 2 diabetic patients. | 2009 | Details |
A26832 | 19690397 | Gerontology | Non-alcoholic fatty liver disease in older people. | 2009 | Details |
A26833 | 19688595 | Dig Dis Sci | Association between nonalcoholic fatty liver disease and coronary artery calcification. | 2009 | Details |
A26834 | 19686415 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease: an expanding problem with low levels of awareness in Hong Kong. | 2009 | Details |
A26836 | 19683013 | Life Sci | Dose dependent development of diabetes mellitus and non-alcoholic steatohepatitis in monosodium glutamate-induced obese mice. | 2009 | Details |
A26842 | 19670918 | Drug Saf | Liver safety in patients with type 2 diabetes treated with pioglitazone: results from a 3-year, randomized, comparator-controlled study in the US. | 2009 | Details |
A26844 | 19667999 | Eur J Gastroenterol Hepatol | Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease. | 2010 | Details |
A26845 | 19666428 | Anadolu Kardiyol Derg | Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography. | 2009 | Details |
A26857 | 19637730 | Rev Invest Clin | [Pathophysiology of non-alcoholic steatohepatitis. An insulin resistance overview]. | 2009 | Details |
A26864 | 19625277 | Gut | The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. | 2009 | Details |
A26878 | 19596472 | J Hepatol | Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease. | 2009 | Details |
A26883 | 19588648 | J Assoc Physicians India | Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2009 | Details |
A26888 | 19584186 | J Clin Endocrinol Metab | Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients. | 2009 | Details |
A26905 | 19559819 | Clin Gastroenterol Hepatol | Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease. | 2009 | Details |
A26913 | 19381124 | Ann Hepatol | Association between type two diabetes and non-alcoholic fatty liver disease in youth. | 2009 | Details |
A26927 | 19533014 | J Gastroenterol | Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease. | 2009 | Details |
A26932 | 19524579 | Gastroenterology | Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. | 2009 | Details |
A26934 | 19519467 | Endocr Metab Immune Disord Drug Targets | Dissecting insulin signaling pathways: individualised therapeutic targets for diagnosis and treatment of insulin resistant states. | 2009 | Details |
A26938 | 19513842 | Dig Dis Sci | Insulin resistance is common in patients with predominantly genotype 3 chronic hepatitis C. | 2009 | Details |
A26959 | 19464069 | J Hepatol | Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status. | 2009 | Details |
A26960 | 19460054 | Intern Med J | Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes. | 2010 | Details |
A26987 | 19408737 | Acta Gastroenterol Latinoam | [Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?]. | 2009 | Details |
A26992 | 19387108 | J Alzheimers Dis | Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis. | 2009 | Details |
A26994 | 19378390 | J Gastroenterol Hepatol | The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease. | 2009 | Details |
A26997 | 19372595 | J Lipid Res | Differential expression of microRNAs in mouse liver under aberrant energy metabolic status. | 2009 | Details |
A26998 | 19371271 | Pediatr Int | Ghrelin and leptin modulate immunity and liver function in overweight children. | 2009 | Details |
A27005 | 19363256 | J Alzheimers Dis | Epidemilogical trends strongly suggest exposures as etiologic agents in the pathogenesis of sporadic Alzheimer's disease, diabetes mellitus, and non-alcoholic steatohepatitis. | 2009 | Details |
A27009 | 19360015 | Obesity (Silver Spring) | Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort. | 2009 | Details |
A27014 | 19353360 | Ann Med | New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD). | 2009 | Details |
A27015 | 19352614 | J Mol Med (Berl) | Molecular mechanisms involved in NAFLD progression. | 2009 | Details |
A27020 | 19337018 | J Endocrinol Invest | Relationship between cerebral arterial pulsatility and carotid intima media thickness in diabetic and non-diabetic patients with non-alcoholic fatty liver disease. | 2009 | Details |
A27022 | 23105825 | Indian J Clin Biochem | Clinicopathological spectrum of non-alcoholic fatty liver disease among patients in Kerala. | 2009 | Details |
A27026 | 19323780 | Liver Int | Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease. | 2009 | Details |
A27035 | 19293782 | Am J Gastroenterol | NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. | 2009 | Details |
A27046 | 19280268 | Obes Surg | Expression of cytokine signaling genes in morbidly obese patients with non-alcoholic steatohepatitis and hepatic fibrosis. | 2009 | Details |
A27047 | 19278843 | Nutr Metab Cardiovasc Dis | Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension. | 2009 | Details |
A27052 | 19266602 | World J Gastroenterol | Liver histology according to the presence of metabolic syndrome in nonalcoholic fatty liver disease cases. | 2009 | Details |
A27075 | 19221674 | Ann Acad Med Singap | Consequences of childhood obesity. | 2009 | Details |
A27078 | 19221528 | Ann Hepatol | Hepatogenous diabetes. Current views of an ancient problem. | 2009 | Details |
A27082 | 19215335 | J Gastroenterol Hepatol | An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. | 2009 | Details |
A27086 | 19202511 | Pediatr Endocrinol Rev | Low birth weight and catch-up-growth associated with metabolic syndrome: a ten year systematic review. | 2008 | Details |
A27087 | 19199918 | Curr Med Chem | Obesity: pathophysiology and clinical management. | 2009 | Details |
A27109 | 19159884 | Atherosclerosis | Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans. | 2008 | Details |
A27119 | 19140227 | World J Gastroenterol | Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. | 2009 | Details |
A27124 | 19131466 | Diabetes Care | Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. | 2009 | Details |
A27135 | 20469672 | Eksp Klin Gastroenterol | [Non-alcoholic fatty liver disease in dyslipidemia and insulin resistance: similarities and differences; differential approach to therapy]. | 2009 | Details |
A27136 | 20387270 | J Alzheimers Dis | Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease. | 2009 | Details |
A27140 | 19105201 | Hepatology | Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH. | 2009 | Details |
A27145 | 19088402 | Endocr J | A novel mouse model for type 2 diabetes and non-alcoholic fatty liver disease: spontaneous amelioration of diabetes by augmented beta cell mass. | 2008 | Details |
A27158 | 19072347 | Expert Rev Gastroenterol Hepatol | Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes. | 2008 | Details |
A27163 | 19065650 | Hepatology | Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. | 2009 | Details |
A27166 | 19055132 | Ned Tijdschr Geneeskd | [Liver cirrhosis in diabetes mellitus; a complication not always recognized]. | 2008 | Details |
A27183 | 19025308 | Rev Esp Enferm Dig | [Molecular basis of obesity-related hepatic steatosis]. | 2008 | Details |
A27185 | 19017926 | Radiology | Nonalcoholic fatty liver disease: rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging. | 2008 | Details |
A27186 | 19016656 | Clin Sci (Lond) | Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis. | 2008 | Details |
A27194 | 19010326 | Gastroenterology | Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. | 2008 | Details |
A27198 | 19002423 | Internist (Berl) | [Are there therapeutic approaches of non-alcoholic fatty liver disease and its complications?]. | 2008 | Details |
A27206 | 18986848 | Clin Gastroenterol Hepatol | Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. | 2008 | Details |
A27217 | 18956297 | Semin Liver Dis | Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. | 2008 | Details |
A27220 | 18956294 | Semin Liver Dis | Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease. | 2008 | Details |
A27224 | 18956290 | Semin Liver Dis | The epidemiology of nonalcoholic fatty liver disease: a global perspective. | 2008 | Details |
A27235 | 18936912 | Naunyn Schmiedebergs Arch Pharmacol | A role for atorvastatin and insulin combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia. | 2008 | Details |
A27242 | 18854760 | J Hypertens | Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients. | 2008 | Details |
A27247 | 18844098 | Zhonghua Yi Xue Za Zhi | [Relationship of liver fat content to insulin resistance and metabolic syndrome]. | 2008 | Details |
A27249 | 18839053 | Acta Diabetol | The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease. | 2008 | Details |
A27251 | 18835952 | Diabetes Care | Serum adipocyte fatty acid-binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients. | 2008 | Details |
A27252 | 18831772 | BMC Gastroenterol | Risk factors associated with non-alcoholic fatty liver disease in subjects from primary care units. A case-control study. | 2008 | Details |
A27259 | 18821470 | Curr Opin Investig Drugs | The endoplasmic reticulum as a potential therapeutic target in nonalcoholic fatty liver disease. | 2008 | Details |
A27273 | 18782455 | BMC Gastroenterol | Resveratrol inhibits nonalcoholic fatty liver disease in rats. | 2008 | Details |
A27287 | 18752331 | Hepatology | Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. | 2008 | Details |
A27293 | 18713300 | J Gastroenterol Hepatol | Polymorphism of human leptin receptor gene is associated with type 2 diabetic patients complicated with non-alcoholic fatty liver disease in China. | 2008 | Details |
A27308 | 18682312 | J Hepatol | Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. | 2008 | Details |
A27318 | 18654060 | Postgrad Med | Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome. | 2008 | Details |
A27320 | 18648737 | J Gastroenterol | Liver diseases and metabolic syndrome. | 2008 | Details |